<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>32</volume><submitter>Liao CY</submitter><pubmed_abstract>In fibrotic tissues, activated fibroblasts remodel the collagen-rich extracellular matrix (ECM). Intervening with this process represents a candidate therapeutic strategy to attenuate disease progression. Models that generate quantitative data on 3D fibroblast-mediated ECM remodeling with the reproducibility and throughput needed for drug testing are lacking. Here, we develop a model that fits this purpose and produces combined quantitative information on drug efficacy and cytotoxicity. We use microinjection robotics to design patterns of fibrillar collagen-embedded fibroblast clusters and apply automated microscopy and image analysis to quantify ECM remodeling between-, and cell viability within clusters of TGFβ-activated primary human skin or lung fibroblasts. We apply this assay to comp</pubmed_abstract><journal>Materials today. Bio</journal><pagination>101800</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12059351</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Novel high throughput 3D ECM remodeling assay identifies MEK as key driver of fibrotic fibroblast activity.</pubmed_title><pmcid>PMC12059351</pmcid><pubmed_authors>Ten Dijke P</pubmed_authors><pubmed_authors>Crawford J</pubmed_authors><pubmed_authors>Hundscheid JHM</pubmed_authors><pubmed_authors>Danen EHJ</pubmed_authors><pubmed_authors>Coornaert B</pubmed_authors><pubmed_authors>Liao CY</pubmed_authors></additional><is_claimable>false</is_claimable><name>Novel high throughput 3D ECM remodeling assay identifies MEK as key driver of fibrotic fibroblast activity.</name><description>In fibrotic tissues, activated fibroblasts remodel the collagen-rich extracellular matrix (ECM). Intervening with this process represents a candidate therapeutic strategy to attenuate disease progression. Models that generate quantitative data on 3D fibroblast-mediated ECM remodeling with the reproducibility and throughput needed for drug testing are lacking. Here, we develop a model that fits this purpose and produces combined quantitative information on drug efficacy and cytotoxicity. We use microinjection robotics to design patterns of fibrillar collagen-embedded fibroblast clusters and apply automated microscopy and image analysis to quantify ECM remodeling between-, and cell viability within clusters of TGFβ-activated primary human skin or lung fibroblasts. We apply this assay to comp</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Jun</publication><modification>2026-06-01T10:24:39.046Z</modification><creation>2026-04-08T11:20:05.069Z</creation></dates><accession>S-EPMC12059351</accession><cross_references><pubmed>40343164</pubmed><doi>10.1016/j.mtbio.2025.101800</doi></cross_references></HashMap>